125971-57-5Relevant articles and documents
The convergent synthesis of CI-981, an optically active, highly potent, tissue selective inhibitor of HMG-CoA reductase
Baumann,Butler,Deering,Mennen,Millar,Nanninga,Palmer,Roth
, p. 2283 - 2284 (1992)
The synthesis of CI-981 is described starting from isobutyrylacetanilide (3) and the key chiral intermediate 2.
Preparation method of atorvastatin calcium isomers
-
Paragraph 0022; 0034; 0053-0054, (2018/09/11)
The invention relates to a preparation method of atorvastatin calcium isomers [R-(R*,R*)]-2-(3-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-2-phenyl-4-[(aniline)carbonyl]-1H-pyrrole-1-calciumenanthate salt (IMP-1 for short) and [R-(R*,R*)]-3-(2-fluorophenyl)-beta, delta-dihydroxyl -5-(1-Methylethyl)-3-phenyl-4-[(anilino)carbonyl]-1H-pyrrole-1- calcium enanthate salt (IMP-2 for short). According to the preparation method, a preparation method of a reference substance is provided for the quality research of drugs, and an important guiding significance is provided for the safe medicationof atorvastatin calcium.
The total synthesis of calcium atorvastatin
Dias, Luiz C.,Vieira, Adriano S.,Barreiro, Eliezer J.
supporting information, p. 2291 - 2296 (2016/03/01)
A practical and convergent asymmetric route to calcium atorvastatin (1) is reported. The synthesis of calcium atorvastatin (1) was performed using the remote 1,5-anti asymmetric induction in the boron-mediated aldol reaction of β-alkoxy methylketone (4) with pyrrolic aldehyde (3) as a key step. Calcium atorvastatin was obtained from aldehyde (3) after 6 steps, with a 41% overall yield.